Archive for the ‘red’ tag

Vytorin – print ad

without comments


There are 2 sources of cholesterol. Food & Family.

Only Vytorin treats both.

Brand name: Vytorin
Generic name/category: Ezetimibe/simvastatin, Statins
Company: Merck/Schering-Plough Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: treatment of dyslipidemia
Target: Consumers (DTC)
Tagline: Treat the 2 sources of cholesterol
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Prevention – December 2009

To see all of this brand's ads on AdPharm, click here

Ezetimibe/simvastatin is a drug combination used for the treatment of dyslipidemia. It is a combination of ezetimibe (best known as Zetia in the United States and Ezetrol elsewhere) and the statin drug simvastatin (best known as Zocor in the U.S.). The combination preparation is marketed by Merck & Co./Schering-Plough Pharmaceuticals (joint venture) under the trade names Vytorin and Inegy.

Ezetimibe reduces blood cholesterol by inhibiting absorption of cholesterol by the small intestine by acting at the brush border of the small intestine and inhibits the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.

Simvastatin is an HMG-CoA reductase inhibitor or statin. It works by blocking an enzyme that is necessary for the body to make cholesterol.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Caltrate Plus

without comments

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Tylenol…

without comments

and 61 more ads for that brand…

See the rest of the Tylenol ads on AdPharm here…

Procrit

without comments

Leopard_Users_spaquet_Desktop_untitled folder_medimedia_bh_20081

Click on image to view ad details and full-size version on AdPharm

Ventavis in PAH

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

In Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Give your PAH patients a second wind

New Ventavis 20 mcg/mL
Shorter treatment times. Higher concentration.

The only inhaled PAH therapy to demonstrate a spectrum of PAH efficacy.

Smart technology from the I-neb AAD by Philips Respironics

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and ischaemia. It was developed by the pharmaceutical company Schering AG and is marketed by Bayer Schering Pharma AG in Europe and Actelion Pharmaceuticals in the USA.

More on Wikipedia

Brand name: Ventavis
Generic name/category: Iloprost, Prostaglandins, Alkynes
Company: Actelion
Country/Market: USA, North America
Indication(s)/use: Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Target: Healthcare Professionals (HCP)
Tagline: A spectrum of inhaled PAH efficacy
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: Chest – September 2009

To see all of this brand’s ads on AdPharm, click here

Alvesco print ads for HCPs in Canada in both French and English

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Choisissez Alveso pour les enfants en pleine croissance.
Un traitement d’entretien de première intention de l’asthme sans aucun effet démontré sur la croissance. (tel que mesuré par le rythme de croissance et par stadiomètre au cours des essais cliniques).

Choose Alvesco for growing kids.
A first-line asthma maintenance therapy with no demonstrated effect on growth. (as measured by growth velocity and stadiometry in clinical trials).

Brand name: Alvesco
Generic name/category: Ciclesonide, Glucocorticoids
Company: Nycomed
Country/Market: Canada, North America
Indication(s)/use: Prophylactic management of steroid-responsive bronchial asthma in patients 6 years of age and older.
Target: Healthcare Professionals (HCP)
Tagline: Asthma control with confidence
Medium: Print ad
Size/duration: single-page
Publication/Aired: Le Médecin Du Québec and CMAJ – September 2009

To see all of this brand’s ads on AdPharm, click here

Claritin RediTabs print ad for HCPs

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Powerful non-drowsy 12 Hr. relief when your patients need it

Recommend new 12 Hr

New 12-hour Claritin RediTabs tablets relieve your patients’ worst allergy symptoms without drowsiness.

#1 pharmacist recommended
OTC Pharmacy Today

Brand name: Claritin
Generic name/category: Loratadine, H1 receptor antagonists, Carbamates
Company: Schering-Plough
Country/Market: USA, North America
Indication(s)/use: allergies, with non-sedating properties
Target: Healthcare Professionals (HCP)
Tagline: Help your patients live Claritin clear
Medium: Print ad
Size/duration: single-page
Publication/Aired: Drug Topics – August 2009

To see all of this brand’s ads on AdPharm, click here